In case reaching a final agreement, API operations are expected to remain in Oss while staff supporting the operations transfer with the business.
No specific details are finalized. The specifics will be subject to discussion and alignment with the Oss Works Council and Trade Union, according to MSD.
Aspen is owned in part by GlaxoSmithKline.